Eileen Appelbaum
Senior Economist and Co-Director, Center for Economic and Policy Research
Senior Economist and Co-Director, Center for Economic and Policy Research
Eileen is a Senior Economist and Co-Director of CEPR and fellow at Rutgers University Center for Women and Work. She has held visiting positions at the Wissenschaftszentrum (Berlin), University of Manchester and Leicester University (UK), University of South Australia, and University of Auckland (New Zealand). Prior to joining CEPR, she held positions as distinguished professor and director of the Center for Women and Work at Rutgers University and as professor of economics at Temple University. She holds a PhD in economics from the University of Pennsylvania.
Since 2010, Eileen’s research has focused on financialization of the economy and the role of private equity in financial engineering and restructuring of companies for financial gain. Her recent work has examined the financialization of health care. She has published more than 50 peer-reviewed articles, chapters in books, working papers, and pieces in an array of outlets, including The Hill and The American Prospect.
Her book, Private Equity at Work: When Wall Street Manages Main Street, coauthored with Rosemary Batt, was selected by the Academy of Management as one of the four best books of 2014 and 2015 and was a finalist for the 2016 George R. Terry award. This book was the first to provide a balanced examination of private equity’s effects on the companies they acquire and the workers in those companies. It has had an important and widely acknowledged impact on research and policy on private equity.
Prior to 2010, Eileen’s research focused on organizational restructuring and outcomes for firms and workers regarding low-wage jobs, new technology and work organization, and work-family policy. She has published peer-reviewed articles in a range of journals, including Review of Radical Political Economics, British Journal of Industrial Relations, JAMA Health Forum, and Advances in Health Care Management. Her book, Unfinished Business: Paid Family Leave in California and the Future of U.S. Work-Family Policy, coauthored with Ruth Milkman, examines the effects of paid family leave in California on employers and employees. It has been widely cited in discussions of national paid family and medical leave policy.
Several of her earlier books — The New American Workplace: Transforming Work Systems in the United States with Rosemary Batt, Low Wage America: How Employers Are Reshaping Opportunity in the Workplace with Annette Bernhardt and Richard Murnane, and Manufacturing Advantage: Why High Performance Work Systems Pay Off with Peter Berg, Thomas Bailey and Arne Kalleberg — were selected by Princeton University for its distinguished list of Noteworthy Books in Industrial Relations and Labor Economics.
Over the past decade, private equity has crept and crawled into all corners of our lives. Everywhere you look across our ruinous, virus-riddled landscape, private equity is there.
COVID-19 has revealed wide racial, ethnic and class disparities in access to health and other care services that can no longer be ignored.
A central problem in contemporary employment relations is the fragmentation of work. This process is occurring in health systems as they decentralize services from hospitals to outpatient centers.
Social infrastructure holds the key to successfully navigating a range of challenges on the horizon. This is nowhere more important than in the care and education of young children.
Private Equity (PE) firms have had their eye on workers’ retirement nest eggs – 401(k) and IRA accounts – since late 2013 when rules on advertising to individuals were relaxed.
Unless Congress and regulators act, private equity will shed its nonperforming assets and feast on new ones. J. Crew is the latest example.
Doctor Ling Min is the first emergency room doctor to be fired for going public with his concerns about poor hospital emergency room safety practices. He won’t be the last.
Hospitals weighed down by debt to their private equity owners set to receive taxpayers’ dollars.
Private equity firms have become major players in the healthcare industry. How has this happened and what are the results?